|Mr. John E. Timberlake||Pres, CEO & Director||654.55k||N/A||1965|
|Mr. Erick J. Lucera CPA, CFA||CFO & Sec.||408k||N/A||1968|
|Mr. Geoffrey H. Jenkins||Exec. VP of Manufacturing, Operations and R&D||328.44k||N/A||1952|
|Dr. Matthew H. Nguyen||Chief Commercial Officer||410.9k||N/A||1970|
|Mr. Joseph Saldanha||Chief Bus. Officer||349.75k||N/A||1965|
Valeritas Holdings, Inc., a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States. The company offers V-Go, a wearable insulin delivery device for basal-bolus therapy. It also develops V-Go Prefill that is in the design-development stage for eliminating the device-filling process and the need for EZ fill refrigeration for patients with Type 2 diabetes; and V-Go SIM for real-time tracking information of basal and bolus dosing utilization. The company sells V-Go to third-party wholesalers and medical supply distributors. Valeritas Holdings, Inc. was founded in 2006 and is headquartered in Bridgewater, New Jersey.
Valeritas Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.